Mode
Text Size
Log in / Sign up
N/A Completed N=257 Randomized Double-blind Treatment

Experience of Pain During Oocyte Retrieval- a Comparison Between Two Aspiration Needles

Source: ClinicalTrials.gov NCT00924885 ↗
Enrolled (actual)
257
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcomePrimary: Visual Analogue Scale — 21.0; 26.0 0-100 mm — p=0.04

Summary

The purpose of the study is to compare the pain experience between the patients that have had their transvaginal oocytes retrieval with ultrasound guidance performed with reduced single lumen needle (Vitrolife Sweden AB, Gothenburg) with the patients that have had follicle aspiration needle, 1.4 outer diameter (Vitrolife Sweden AB, Gothenburg), during the procedure.

Outcome Measures

OutcomeResultp-value
PRIMARY
Visual Analogue Scale
21.0; 26.0 0.04 sig
SECONDARY
Intervention Because of Bleeding
40; 24; 80; 93; 6; 7

Eligibility Criteria

Inclusion Criteria

  • The patient has signed an informed consent form before the oocyte retrieval
  • The patient is undergoing oocyte retrieval with local anaesthesia
  • The patient can speak and understand Swedish

Exclusion Criteria

  • The patient has previously participated in Vitrolife-needle-01 study
  • The patient has a body mass index ≥35
  • Other contra indicator for oocyte retrieval
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00924885). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search